Akebia Shares Spike Sharply Higher As Traders Get Word Of Earlier $90 Price Target By Morgan Stanley

By: via Benzinga
Shares of Akebia Therapeutics (NASDAQ: AKBA) are seeing a somewhat surprising sharp spike higher Monday afternoon following a CNBC ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.